Thats something to keep an eye on. Other companies are developing once-a-month injectable formulations
Bias in meta-analysis detected by a simple, graphical test
What to Expect in Month 2 Peak nausea: Weeks 6-8 worst for most patients, especially mornings Food aversions: Foods you loved suddenly repulsive (especially meat, coffee) Early satiety: Feel full after 3-4 bites, physical discomfort if you push it Fatigue increases: Combination of medication adjustment and reduced calorie intake Bowel unpredictability: Constipation one day, diarrhea the next Mental fog: Some patients report difficulty concentrating Research from the New England Journal of Medicine on incretin therapies shows this peak-and-resolution pattern is universal across GLP-1 and GIP agonists
Diabetes develops when the pancreas either makes no insulin, not enough insulin, or plenty of insulin, but the cells become resistant to it
These groups were evaluated on how the effect of GLP-1 had on apoptosis
[DOI] [PMC free article] [PubMed] [Google Scholar] 66.Nauck MA, Friedrich N
